AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue463418173235
Cost of Revenue41,38233,93014,53815,994
Gross Profit-40,919-33,512-14,365-15,759
Operating Expenses
Research Development41,38241,38241,38241,382
Selling General and Administrative13,67412,0966,9706,263
Non Recurring----
Total Operating Expenses56,62147,48222,98723,815
Operating Income or Loss-56,158-47,064-22,814-23,580
Income from Continuing Operations
Total Other Income/Expenses Net-7,889-23,728-4814,973
Earnings Before Interest and Taxes-56,158-47,064-22,814-23,580
Interest Expense----
Income Before Tax-64,047-70,792-23,295-18,607
Income Tax Expense73---
Minority Interest----
Net Income From Continuing Ops-64,120-70,792-23,295-18,607
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-64,120-70,792-23,295-18,607
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-64,120-70,792-23,295-18,607